Cardio Diagnostics Holdings today announced a 1-for-30 reverse stock split of its common stock effective with the market ...

Tilray has a proposed reverse stock split on the table that will help it avoid getting delisted from the Nasdaq. This move ...

A new company is set to join O'Reilly Automotive and Fastenal as 2025's high-profile stock splits. Wall Street's newest stock ...

Effective as of Commencement of Trading on May 9, 2025IRVINE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences ...

Cardio Diagnostics (NASDAQ:CDIO) announced on Thursday, a 1-for-30 reverse stock split of its common stock effective with the market opening on May 13, 2025. The reverse stock split is part of the ...

BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that its board of ...

The new CUSIP number for the common stock will be 09061H406. The Reverse Stock Split is intended to increase the bid price of the common stock to enable Biomerica to regain compliance with the ...

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today announced that it expects to implement a 1 ...

Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend” or the “Company”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease ...

Cardio Diagnostics Holdings, Inc. (“Cardio” or the “Company”) (NASDAQ: CDIO), today announced a 1-for-30 reverse stock split of its common stock effective with the market opening on May 13 ...